Peer Review History
| Original SubmissionMay 11, 2020 |
|---|
|
PONE-D-20-11075 HIV testing and seroprevalence among couples of people living with HIV in China: a meta-analysis PLOS ONE Dear Dr. Xianhong Li, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by April 8, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Qigui Yu, M.D./Ph.D Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: ● The name of the colleague or the details of the professional service that edited your manuscript ● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) ● A clean copy of the edited manuscript (uploaded as the new *manuscript* file) Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: First Read: The paper is well written and does a great job reporting all necessary components of a systematic review and meta-analysis. The research questions and purpose are clear and straightforward. The search strategy and review methodology were clearly described and appropriate, however the manuscript needs to be reviewed for grammar and syntax, preferably by a native English speaker to improve clarity of your prose. Below are some of my concerns and questions. General comments and questions: To examine CHT and HIV prevalence among Chinese living with HIV - isn't this 100% prevalence? To be accurate should this be HIV prevalence among Chinese people. Or are you hoping to estimate prevalence of HIV among Chinese people who do not know their status? Or maybe discordant couples? From further reading, I am assuming Chinese PLWH = Serodiscordant Chinese couples -> This needs to be better clarified and I have pointed it out in a few places, but this needs to be used consistently throughout the paper Abstract: It would be helpful to know how many studies attributed to each of the analysis with the estimates, it would clarify why MSM is stated to have 10 studies, however table 2 shows 8 studies for Uptake rate and 10 for HIV prevalence. Line 21-22: "…among couples of Chinese people living with HIV…" - it is unclear whether or not both have HIV (seroconcordant) or only one person has HIV (serodiscordant). Assuming it is the latter, this needs to be written to be explicitly and clear throughout the paper. Line 28-29: "We conducted three studies among…" - this is confusing, are there words missing? Should it be, "We conducted a subgroup analysis…"? Line 36-37: "Almost two-thirds of Chinese couples living with HIV have had an HIV test, of which 28% were positive" - this implies that of the two-thirds that’s were tested, 28% were HIV positive. Were the 28% HIV-positive among the 65% who were tested or are these estimates separately calculated? Introduction: Line 45-46: the goals of 90-90-90 are: 90% of all people living with HIV will know their HIV status-90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy-90% of all people receiving antiretroviral therapy will have viral suppression. Testing coverage is not specified in the goals. Line 53-54: "…encouraging CHT among PLWH could identify additional HIV infected individuals…" This is a very confusing statement, I think PLWH is meant to be "undiagnosed" or "serodiscordant"? Similar language is used throughout the introduction and needs to be clarified. Methods: Line 70: "…the proportion of CHT among Chinese PLWH…" for clarification, what is the denominator in this? Is it Chinese people living with HIV or Chinese couples or serodiscordant couples? This is somewhat described in the footnote in table 1, but this should be included in the text Line 101: what were some of the variables extracted from the included studies? Was timeframe of testing abstracted, lifetime vs recent testing? This could have implications for interpreting results. Line 118-119: were the couples assumed to be sexually monogamous couples or was this information collected? Line108: Can you describe what some of these 8 items are assessing? Even in the supporting documents the scoring sheet does not describe the questions. Line 121: What is the threshold for determining if a study does impact the pooled estimate in a meaningful way Results: The Uptake of CHT and Proportion of HIV among PLWH couples could be presented in tabular format, maybe integrated with table 2? The figures themselves can be difficult to interpret for readers who are not familiar with forest plots. Line 136: Can an additional analysis of CHT and HIV prevalence be conducted among the some of the larger provinces that had a lot of data reported for them? This would be interesting to see. Line 178: did any of the subgroup analyses uncover any sources of heterogeneity? Line 200: The Eggers test may not have shown statistical evidence of publication bias, however I must disagree about the assessment of the funnel plots. Figure 4 seems to indicate there may be missing studies at the bottom right of the graph. Figure 5 seems to indicate some missing studies from the bottom left of the graph. However, this may not be helpful as these tests and bias assessments do not work well when heterogeneity is high. I think justifying lack of evidence for bias could be from your comprehensive search (of published and gray literature) would better serve the paper rather than the statistical testing. Discussion: The couples are now described as discordant sexual partners - This is the language that should be used throughout the paper rather than referring to them as Chinese PLWH couples. Are there any efforts to increase serodiscordant couple HIV testing for the Chinese population? Are there any outside China that could be adapted and used? Another potential limitation is the generalizability of the findings, meaning how well are these Chinese discordant couples included in the studies representative of all Chinese serodiscordant couples? Tables and figures: The figures need to be labeled and annotated in order for readers to be able to understand the them as a standalone result. Reviewer #2: Please review and edit the article to be clearer. While the paper did meet expectations laid out in the abstract and the conclusions were well-thought out and appropriate given the data, there were several areas where more concise/clear language could have been used. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Jeffrey S Becasen Reviewer #2: No NOTE: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
HIV testing and seroprevalence among couples of people diagnosed with HIV in China: A meta-analysis PONE-D-20-11075R1 Dear Dr. Li We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Qigui Yu, M.D./Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-20-11075R1 HIV testing and seroprevalence among couples of people diagnosed with HIV in China: A meta-analysis Dear Dr. Li: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Qigui Yu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .